Scientific Sessions 2025  /  Featured Science in EP  /  Discussant
Logo

American Heart Association

  74
  0

Final ID:

Discussant

  • Morin, Daniel  ( Univ of CA San Francisco , San Francisco , California , United States )
    • Author Disclosures:
    Daniel Morin: DO have relevant financial relationships ; Consultant:Zoll:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Speaker:Zoll:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Featured Science in EP

Monday, 11/10/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Pulsed Field Ablation versus Sham Ablation to Treat Atrial Fibrillation
(The PFA-SHAM Trial)

Osmancik Pavel, Karel Tomas, Sediva Lucie, Stepanek Lubomir, Lekesova Veronika, Hala Pavel, Vesela Jana, Karch Jakub, Filipcová Vera, Fischer Jakub, Whang William, Neuzil Petr, Reddy Vivek, Hozmanova Jana, Petru Jan, Hozman Marek, Kralovec Stepan, Herman Dalibor, Tichy Marco, Waldauf Petr

Efficacy and safety of flecainide compared to amiodarone for atrial fibrillation cardioversion in patients with Coronary Artery Disease and preserved ejection fraction. FLECA-ED trial

Tsioufis Panagiotis-anastasios, Patsilinakos Sotirios, Kafkas Nikos, Tsioufis Konstantinos, Tsiachris Dimitris, Argyriou Nikolaos, Botis Michail, Kordalis Athanasios, Doundoulakis Ioannis, Antoniou Christos-konstantinos, Matthaiopoulos George, Zamanis Ioannis

More abstracts from these authors:
Relationships Between Degree of Obesity, Transthoracic Impedance, and Cardioversion Efficacy

Sanchez Alexandra, Morin Daniel, Murphy Barret, Aymond Joshua, Bernard Michael, Hiltbold Aimee, Khatib Sammy, Polin Glenn, Rogers Paul, Castine Michael

You have to be authorized to contact abstract author. Please, Login
Not Available